Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingwei Tian

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
International Journal of Immunopathology and Pharmacology|April 11, 2019
PCC0208018 exerts antitumor effects by activating effector T cellsMinmin Ge, Zhengping Hu, Xiao Chen, et al.
Scientific Reports|April 8, 2016
Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake InhibitorFangxi Zhang, Jing Shao, Jingwei Tian, et al.
Pharmacology Research & Perspectives|April 5, 2025
The TAAR1 Agonist PCC0105004 Regulates Amygdala Synaptic Plasticity to Alleviate Anxiety-Like Behaviors in RatsYingtian Zhang, Wei Zhang, Linyao Yu, et al.
Neuroscience Letters|January 13, 2005
Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in ratsJingwei Tian, Fenghua Fu, Meiyu Geng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 2, 2009
Protections of SMND-309, a novel derivate of salvianolic acid B, on brain mitochondria contribute to injury amelioration in cerebral ischemia ratsJingwei Tian, Fenghua Fu, Guisheng Li, et al.
Toxicology and Applied Pharmacology|August 24, 2020
WITHDRAWN: PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain modelChunmei Li, Chunyu Su, Zhezhe Wang, et al.
Scientific Reports|April 7, 2019
PCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrationsQiuju Dong, Pengfei Yu, Liang Ye, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 4, 2018
Pharmacokinetics of S-EPA, and its inhibition on indoleamine 2,3-dioxgenase: a case of sulfur-substitution affecting distributions in blood cellsWenyan Wang, Xuhui Zhuang, Heyuan Sun, et al.
Plos One|January 1, 2015
NSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesisPengfei Yu, Liang Ye, Hongbo Wang, et al.
Pharmacology & Therapeutics|May 24, 2022
MicroRNAs in drug addiction: Current status and future perspectivesYue Zhao, Feng Qin, Shuang Han, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
International Journal of Immunopathology and Pharmacology|April 11, 2019
PCC0208018 exerts antitumor effects by activating effector T cellsMinmin Ge, Zhengping Hu, Xiao Chen, et al.
Scientific Reports|April 8, 2016
Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake InhibitorFangxi Zhang, Jing Shao, Jingwei Tian, et al.
Pharmacology Research & Perspectives|April 5, 2025
The TAAR1 Agonist PCC0105004 Regulates Amygdala Synaptic Plasticity to Alleviate Anxiety-Like Behaviors in RatsYingtian Zhang, Wei Zhang, Linyao Yu, et al.
Neuroscience Letters|January 13, 2005
Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in ratsJingwei Tian, Fenghua Fu, Meiyu Geng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 2, 2009
Protections of SMND-309, a novel derivate of salvianolic acid B, on brain mitochondria contribute to injury amelioration in cerebral ischemia ratsJingwei Tian, Fenghua Fu, Guisheng Li, et al.
Toxicology and Applied Pharmacology|August 24, 2020
WITHDRAWN: PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain modelChunmei Li, Chunyu Su, Zhezhe Wang, et al.
Scientific Reports|April 7, 2019
PCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrationsQiuju Dong, Pengfei Yu, Liang Ye, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 4, 2018
Pharmacokinetics of S-EPA, and its inhibition on indoleamine 2,3-dioxgenase: a case of sulfur-substitution affecting distributions in blood cellsWenyan Wang, Xuhui Zhuang, Heyuan Sun, et al.
Plos One|January 1, 2015
NSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesisPengfei Yu, Liang Ye, Hongbo Wang, et al.
Pharmacology & Therapeutics|May 24, 2022
MicroRNAs in drug addiction: Current status and future perspectivesYue Zhao, Feng Qin, Shuang Han, et al.
Pageof 19